![Vaccine vial](https://assets.obj.ca/2022/07/56l0w3oX-AdobeStock_327257834-300x200.jpeg)
Biotech firm gets US$33M boost for Ottawa-developed COVID-19 vaccine targeting new variants
Massachusetts-based VBI Vaccines began clinical trials at the Ottawa Hospital this week on the first version of its product.
Biotech firm gets US$33M boost for Ottawa-developed COVID-19 vaccine targeting new variants
Massachusetts-based VBI Vaccines began clinical trials at the Ottawa Hospital this week on the first version of its product.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored